Rgenta Therapeutics
company
Funding Round
Series A
Money Raised
$ 52M
Propotion
-
Post Valuation
-
Current Round Investors
| Investor Name | Invest Money | Lead Investor | Propotion | |
|---|---|---|---|---|
| AstraZeneca | - | Yes | - | Detail |
| CICC | - | Yes | - | Detail |
| Boehringer Ingelheim Venture Fund | - | - | - | Detail |
| Delos Capital | - | - | - | Detail |
| Kaitai Capital | - | - | - | Detail |
| Korean Investment Partners | - | - | - | Detail |
| Legend Star | - | - | - | Detail |
| Lilly Asia Ventures | - | - | - | Detail |
| Matrix Partners China | - | - | - | Detail |
| Vivo Capital | - | - | - | Detail |
Historical Financing
| Announced Date | Round | Money Raised | Investors | |
|---|---|---|---|---|
| Feb 7, 2022 | Series Unknown | $ 8.91M | Detail | |
| May 25, 2021 | Seed | $ 18M | Kaitai Capital,Lilly Asia Ventures,etc. | Detail |
| Jan 21, 2020 | Series Unknown | $ 10.03M | Detail | |
| Apr 2, 2020 | Seed | $ 20M | Boehringer Ingelheim Venture Fund,Kaitai Capital,etc. | Detail |
